picking a clinical trial for pleural meso - what actually matters

I'm peritoneal not pleural so different beast, but the trial selection process is honestly what kept me sane these last couple months. I've been deep in the research since my November diagnosis and I'm evaluating HIPEC surgery right now, so I'm looking at trial eligibility from that angle instead.

What actually mattered to me when I was vetting options: I pulled the full protocol documents, not just summaries. Like the actual FDA filings if I could get them. That's where you find what they're really measuring. One trial I looked at was tracking progression-free survival at 12 months but another was looking at overall survival data at 24 months. Huge difference in what you're signing up for, right? The marketing materials never highlight that distinction.

I also cross-referenced each trial's historical data. There's a site called clinicaltrials.gov where you can see results from completed phases. I found one study that looked promising until I saw their previous cohort had about a 40% dropout rate due to toxicity. That matters more than the drug name, honestly.

The logistics piece you mentioned is real. I'm in Cleveland so I mapped out drive times to each hospital running the trials I qualified for. One site required weekly visits for 16 weeks. Another was every other week after initial loading. When you're already dealing with fatigue and nausea, that's not a small thing. I keep a symptom journal so I could actually project what my schedule would look like.

My oncologist here is good but I got a consultation call with someone at a major cancer center specifically about trial selection back in January. That second opinion on trial choice, not just diagnosis, changed how I was thinking about it. Worth the effort.

I've been looking at trial protocols obsessively since November and one thing I wish someone had told me upfront is to actually pull the trial's previous publications. Like not just the phase you're entering, but what they published from earlier phases. I found a 2023 paper from one of the centers I was considering and their median progression-free survival was basically 4 months worse than they were advertising in the recruitment materials. That's... a meaningful difference when you're trying to decide if you're spending your time and body on something.

Also ask them point blank what their protocol does if you progress. Do they keep you in the trial, do they boot you out, can you switch to something else while still under their care. I have my symptom journal going back to September with specifics on ascites accumulation and pain levels, and when I asked one trial coordinator about their progression criteria they got really vague on what happens after. Turns out they stop the trial at first imaging sign of progression and then you're just... loose in the system again. That matters a lot more than whether the hospital cafeteria is good.

One more thing since you mentioned distance and time commitment. I'm in Cleveland so I looked at local options first, but I actually ended up going with a center 90 minutes away because they had weekly labs instead of bi-weekly and their imaging schedule was tighter. For peritoneal especially, that monitoring matters. The drive sucks but if something's going sideways I'd rather know in 2 weeks not 4.

What stage are you exactly and have they given you a sense of how fast yours is progressing?

Yeah man, the weekly commitment thing is huge and nobody really talks about it straight. I did my EPP back in February at UMass Medical up in Worcester and that recovery alone was like a 6-week tune-up, so when my onc mentioned trials I had to think about what I could actually handle. Turns out one of the protocols she mentioned wanted me there every single week for the first 4 months, sometimes twice a week, and I live in Detroit. That's not gonna fly for me at my age, plus the gas money adds up fast even when you're retired.

What actually mattered to me was asking them point blank: what happens if I miss an appointment, how much flexibility is there, and do they keep going with you if you need a break. The dropout rates thing is smart but honestly I cared more about whether they'd boot me out if life got messy. My surgeon had done a couple trials before so I asked her which one she'd pick if she was in my shoes, not which one looked best on paper. She basically said the one with the most experience managing side effects during the actual appointments, not just the one with the fanciest drug name.

One thing I didn't see mentioned yet - call the actual trial coordinator, not just your oncologist's nurse. Talk to the person who's actually gonna be scheduling you and running your bloodwork. They'll tell you real stuff about how organized the place is and whether they actually give a crap if you're having a rough week.

We're in basically the same situation man. Stage II, diagnosed October, surgery December at Balboa. Still waiting on my VA claim from November, which is its own special kind of frustrating but yeah, another story.

I went through the trial selection thing a couple months back and honestly the first thing I did was ask my oncologist point blank which one she'd actually enroll her own family member in. Not which one looks best on paper. Which one would she choose. That got a real answer instead of the clinical speech.

For me the weekly commitment mattered way more than I expected. I'm looking at a TTFields trial right now but the protocol is every single week at the hospital plus home monitoring. I'm okay with that because I'm retired and San Diego's close, but I talked to another vet who dropped out because he was driving two hours each way and it became a second job. The drug could be perfect but if you can't actually do the trial it doesn't matter.

The dropout rates thing you mentioned is solid. Ask them for their numbers. Not just overall but specifically why people leave. Medical reasons versus couldn't handle the schedule versus toxicity. That tells you something real.

One thing nobody talks about enough is whether they're actually looking at quality of life metrics or just tumor response. Some trials only care if your CT scans look better. Some measure whether you can actually breathe better or have less pain. Those aren't always the same thing and for us that matters.

VA hospital versus civilian I'd lean civilian if you have the option. VA's good for some things but their trial infrastructure is slower and the paperwork overlap is a nightmare. I'm doing mine at a civilian center and my oncologist can actually talk to my VA primary care doctor without it being a three week process.

What trials are you actually looking at.

We're in almost the same boat man. Stage II, diagnosed October, surgery December at Balboa actually. Camp Lejeune 78 to 82 here too, barracks building 2847 if any of that rings a bell for you.

I looked at three trials before going with one and honestly the dropout rates thing matters way more than I expected. One trial had like 40 percent of people pulling out before completion, which tells you something about the side effects or the time commitment even if they don't say it directly. My oncologist at Balboa didn't want to talk about that number but I asked anyway and got it from the trial coordinator.

The weekly commitment is huge. One trial wanted me in San Diego five days a week for the first two months. That's doable for me since I'm local but it would've killed me financially if I still had to drive from anywhere else. Another trial was three days a week but only for one month then dropped to monthly. That second one looked better on paper until I actually read the fine print about what "monitoring" meant on those off weeks. Turns out you're still responsible for getting blood work done wherever you live.

Ask them straight up about what happens if you respond well versus if you don't. Some trials are designed to show they don't make things worse, not that they actually work. Some are looking at longer term stuff. My trial is following people for two years post-treatment because they want real data, not just the six month window where everyone looks good. I liked that better than the trials that just measured initial response.

VA claim stuff is its own nightmare but don't let that push you into a trial you're not confident about. I'm still waiting too. Filed November, nothing yet. The trials don't care about your VA status though so at least that's not tied together.

We went through this exact thing back in August when they cleared me for trials after the pleurectomy. My oncologist at the VA here in Norfolk had me look at three different protocols and honestly the marketing stuff does blur everything together.

What actually mattered to us was dropout rates and why people were dropping. One trial had like 40 percent people bailing out because of side effects hitting harder than expected. That's real information. My wife pulled the actual study documents from the NIH database and read through the adverse event sections. Sounds tedious but it tells you what you're actually signing up for.

Second thing was the weekly commitment. I was looking at one that required me to be at the hospital every single week for bloodwork and imaging for a year straight. That's not just inconvenient, that wears on you. The one I ended up considering had every other week after month three, which meant I could still do some light work and not feel like a full-time patient. Distance matters too. Don't underestimate it.

Ask them point blank about long-term follow-up. Some trials only track you for 12 months and then you're done. That's useless for figuring out what actually helped. You want sites that keep data going out 24 months minimum. And ask about what happens if you need to stop. Can you get regular treatment instead or are you stuck waiting.

VA sites versus civilian, I almost went civilian because the VA move can be slow. But my VA oncologist at the Hampton facility actually had good connections with the trial coordinators. Saved time. Just depends on how sharp your VA team is.

Joe and I went through this exact thing back in November when we were deciding between two immunotherapy trials at Moffitt here in Tampa. One was local, one would've meant driving to Jacksonville every other week. Sounds simple but that's actually where we started because honestly the logistics matter way more than people admit.

What we learned is you gotta ask about the trial's phase and what they're actually measuring. Phase II trials care about safety and dosing, phase III is looking at whether it actually works better than standard treatment. That's not marketing stuff, that's the whole difference between "we think this might help" and "we have evidence this helps." Joe's oncologist at Moffitt walked us through that and suddenly the choices made more sense.

The dropout rates thing you mentioned, yeah that matters. We asked how many people had quit early and why. Turns out one trial had like a 40% dropout rate in their last cohort because of side effects, and the hospital just casually mentioned that when we pressed. The other one was lower. That's not small stuff.

One thing nobody tells you is to ask about what happens after the trial ends. Do they keep treating you if you respond well? Does your insurance have to cover it? Because getting good results on a trial drug and then not being able to access it is its own nightmare. We asked that question in week two of looking and it changed which trial made sense for us.

I can't speak to VA sites versus civilian but I'd guess the advantage of civilian centers is they usually have more trial options running at once, so you're not locked into whatever one program they've got going. That flexibility might matter if the first thing isn't working.

How's your energy level right now? That's honestly something to factor in too.